Merit Medical Systems Cash on Hand 2010-2023 | MMSI

Merit Medical Systems cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Merit Medical Systems Annual Cash on Hand
(Millions of US $)
2023 $587
2022 $58
2021 $68
2020 $57
2019 $44
2018 $67
2017 $32
2016 $19
2015 $4
2014 $7
2013 $7
2012 $10
2011 $10
2010 $4
2009 $6
Merit Medical Systems Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $587
2023-09-30 $59
2023-06-30 $72
2023-03-31 $58
2022-12-31 $58
2022-09-30 $51
2022-06-30 $63
2022-03-31 $54
2021-12-31 $68
2021-09-30 $69
2021-06-30 $70
2021-03-31 $59
2020-12-31 $57
2020-09-30 $45
2020-06-30 $50
2020-03-31 $50
2019-12-31 $44
2019-09-30 $37
2019-06-30 $35
2019-03-31 $50
2018-12-31 $67
2018-09-30 $52
2018-06-30 $44
2018-03-31 $34
2017-12-31 $32
2017-09-30 $23
2017-06-30 $38
2017-03-31 $26
2016-12-31 $19
2016-09-30 $17
2016-06-30 $10
2016-03-31 $5
2015-12-31 $4
2015-09-30 $6
2015-06-30 $12
2015-03-31 $10
2014-12-31 $7
2014-09-30 $6
2014-06-30 $9
2014-03-31 $13
2013-12-31 $7
2013-09-30 $9
2013-06-30 $13
2013-03-31 $9
2012-12-31 $10
2012-09-30 $9
2012-06-30 $10
2012-03-31 $10
2011-12-31 $10
2011-09-30 $6
2011-06-30 $63
2011-03-31 $3
2010-12-31 $4
2010-09-30 $5
2010-06-30 $4
2010-03-31 $6
2009-12-31 $6
2009-09-30 $6
2009-06-30 $5
2009-03-31 $16
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.299B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.359B 18.83
Becton Dickinson (BDX) United States $67.554B 19.62
West Pharmaceutical Services (WST) United States $28.238B 47.74
Cardinal Health (CAH) United States $25.184B 15.14
Align Technology (ALGN) United States $23.613B 45.61
Cooper (COO) United States $17.928B 27.13
Labcorp (LH) United States $17.493B 14.94
Henry Schein (HSIC) United States $9.406B 16.27
DENTSPLY SIRONA (XRAY) United States $6.412B 16.90
Patterson (PDCO) United States $2.346B 11.24
STAAR Surgical (STAA) United States $2.337B 73.57
CONMED (CNMD) United States $2.156B 19.56
Atrion (ATRI) United States $0.747B 38.46
Lifevantage (LFVN) United States $0.079B 12.85
Pro-Dex (PDEX) United States $0.065B 24.67
Biolase (BIOL) United States $0.005B 0.00